NCT04895657View on ClinicalTrials.gov

Extended-infusion of Piperacillin-Tazobactam Versus Intermittent Infusion

PHASE4CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

July 27, 2018

Primary Completion Date

January 26, 2020

Study Completion Date

January 26, 2020

Conditions
Gram-Negative Infections
Interventions
DRUG

Piperacillin/Tazobactam Continuous infusion

Continuous infusion

DRUG

Piperacillin/Tazobactam Intermittent infusion

Intermittent infusion

Trial Locations (1)

Unknown

Cairo University Hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04895657 - Extended-infusion of Piperacillin-Tazobactam Versus Intermittent Infusion | Biotech Hunter | Biotech Hunter